{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:58:51Z","timestamp":1769043531035,"version":"3.49.0"},"reference-count":10,"publisher":"American Medical Association (AMA)","issue":"10","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2022,9,13]]},"DOI":"10.1001\/jama.2022.13468","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:21:03Z","timestamp":1663082463000},"page":"980","source":"Crossref","is-referenced-by-count":22,"title":["Treatment of Genetic Diseases With CRISPR Genome Editing"],"prefix":"10.1001","volume":"328","author":[{"given":"Matthew J.","family":"Kan","sequence":"first","affiliation":[{"name":"Division of Allergy, Immunology, and Bone Marrow Transplantation, Department of Pediatrics, University of California, San Francisco"},{"name":"Pediatric Scientist Development Program, Eunice Kennedy Shriver National Institute of Child Health and Human Development, San Francisco, California"},{"name":"Innovative Genomics Institute, University of California, Berkeley"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer A.","family":"Doudna","sequence":"additional","affiliation":[{"name":"Innovative Genomics Institute, University of California, Berkeley"},{"name":"Department of Molecular and Cell Biology, Department of Chemistry, and California Institute for Quantitative Biosciences (QB3), University of California, Berkeley"},{"name":"Howard Hughes Medical Institute, University of California, Berkeley"},{"name":"Molecular Biophysics & Integrated Bioimaging Division, Lawrence Berkeley National Laboratory, Berkeley, California"},{"name":"Gladstone-UCSF Institute of Genomic Immunology, San Francisco, California"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"6096","key":"jit220010r1","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1126\/science.1225829","article-title":"A programmable dual-RNA-guided DNA endonuclease in adaptive bacterial immunity.","volume":"337","author":"Jinek","year":"2012","journal-title":"Science"},{"issue":"21","key":"jit220010r2","doi-asserted-by":"publisher","first-page":"9305","DOI":"10.1128\/MCB.24.21.9305-9316.2004","article-title":"Genetic steps of mammalian homologous repair with distinct mutagenic consequences.","volume":"24","author":"Stark","year":"2004","journal-title":"Mol Cell Biol"},{"issue":"7603","key":"jit220010r3","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1038\/nature17946","article-title":"Programmable editing of a target base in genomic DNA without double-stranded DNA cleavage.","volume":"533","author":"Komor","year":"2016","journal-title":"Nature"},{"issue":"7785","key":"jit220010r4","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1038\/s41586-019-1711-4","article-title":"Search-and-replace genome editing without double-strand breaks or donor DNA.","volume":"576","author":"Anzalone","year":"2019","journal-title":"Nature"},{"issue":"8","key":"jit220010r5","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1038\/s41580-019-0131-5","article-title":"The next generation of CRISPR-Cas technologies and applications.","volume":"20","author":"Pickar-Oliver","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"issue":"6481","key":"jit220010r7","doi-asserted-by":"publisher","DOI":"10.1126\/science.aba7365","article-title":"CRISPR-engineered T cells in patients with refractory cancer.","volume":"367","author":"Stadtmauer","year":"2020","journal-title":"Science"},{"issue":"5","key":"jit220010r8","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1038\/s41591-020-0840-5","article-title":"Safety and feasibility of CRISPR-edited T cells in patients with refractory non-small-cell lung cancer.","volume":"26","author":"Lu","year":"2020","journal-title":"Nat Med"},{"issue":"7859","key":"jit220010r10","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1038\/s41586-021-03534-y","article-title":"In vivo CRISPR base editing of PCSK9 durably lowers cholesterol in primates.","volume":"593","author":"Musunuru","year":"2021","journal-title":"Nature"},{"key":"jit220010r6","unstructured":"Locatelli F, Frangoul H, Corbacioglu S, et al. Efficacy and safety of a single dose of CTX001 for transfusion-dependent beta-thalassemia and severe sickle cell disease. June 12, 2022. https:\/\/bit.ly\/3Ak5Ao4"},{"key":"jit220010r9","unstructured":"Intellia and Regeneron present updated interim data from phase 1 study of CRISPR-based NTLA-2001 for the treatment of transthyretin (ATTR) amyloidosis demonstrating that deep serum TTR reductions remained durable after a single dose. June 24, 2022. https:\/\/ir.intelliatx.com\/news-releases\/news-release-details\/intellia-and-regeneron-present-updated-interim-data-phase-1"}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/articlepdf\/2796264\/jama_kan_2022_it_220010_1662674888.65124.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T15:21:06Z","timestamp":1663082466000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2796264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,13]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,9,13]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2022.13468","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2022,9,13]]}}}